BLOG: Last year we asked supporters to sign a petition for better access to mpMRI scans in Wales. Our Policy Manager, Tim Windle, gives an update on the progress made so far.
The National Institute for Health and Care Excellence has recommended pre-biopsy mpMRI scans and a host of other improvements to diagnosis and treatments for prostate cancer become standard NHS practice across the UK. While we back the proposals, we're calling for enough scanners and trained staff to deliver them.
BLOG: Ahead of the Budget announcement on 29 October, our chief executive Angela Culhane explains why now is the time to really crack earlier diagnosis of the most common cancer in men and the key investments needed to make sure it happens.
Theresa May used her Conservative Party speech today to announce investment in the latest scanners and 'one-stop' centres to radically improve cancer survival rates in the UK. While welcome, we hope they'll be part of a broader NHS plan to help us reach a national screening programme for prostate cancer.
Our recent Freedom of Information request to the NHS showed access to the latest diagnostic scans before a biopsy was worse in Wales than the other home nations. Find out why, what we're doing about it and how you can help.
We're calling on the NHS to make rollout of the revolutionary diagnostic technique for prostate cancer a priority, after new data shows a huge variation in the availability and quality of mpMRI scans across the UK. Check out how your local hospitals are performing in our online map, and find out more about the first clinical consensus on mpMRI we've helped to create.
When Raymond Starr was diagnosed with prostate cancer last year, he was refused an mpMRI on the NHS because there are no scanners available in North Wales. He's now working with us to make sure the revolutionary diagnostic technique is available to all men in the UK.
New research backed by us and the Movember Foundation has shown that a type of ultrasound scan, which can detect the stiffness of the prostate, may be able to spot aggressive cancer.
Evidence continues to mount for giving men an mpMRI scan before a prostate biopsy after an international trial of 500 men showed that mpMRI-guided biopsies help to catch more aggressive cancers and fewer harmless cancers.
Results of a report released today have shown that the average time it takes for a man to receive a diagnosis of prostate cancer in England is 56 days following referral – far longer than the 28 day target that health officials are working towards and the average 14 day diagnosis period for breast cancer. We look into the reasons behind this dramatic difference and what is being done about it.